Macrogenics (MGNX)Officer sold ~$129K

~$129K

Approx. value · 31K sh @ $4.15

Traded

Aug 19, 2026

Filed

Aug 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 30, 2026Company filing · Form 8-K · Acquisition or sale, Reg FDCompleted buying or selling a business or assets, and shared information with investors“Effective as of June 30, 2026, MacroGenics, Inc. (the “ Company ”) completed the previously announced sale (the “ Closing ”) of certain assets and liabilities related to its GMP manufacturing operations, including its CDMO business (the “ CDMO Operations ”) conducted by the Company at its manufacturing facility located at 9704 Medical Center Drive, Rockville, Maryland and related warehouse operations located at 4735…”
2. Jul 1, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.”
3. Aug 13, 2026Company filing · Form 8-K · ResultsReported its results
4. Aug 19, 2026 · this disclosureInsiderOfficer sold ~$129K of MGNX shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Macrogenics

For Macrogenics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MGNX page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Macrogenics

• SEC Form 13F-HRFeb 17, 2026
• SEC Form 4Aug 21, 2025
• SEC Form 4Aug 21, 2025
• SEC Form 4Feb 19, 2025
• SEC Form 13F-HRFeb 18, 2025

Everything OQRO holds on this company is on its MGNX page.